EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 19 July 2018

IMI2 – Calls 15 and 16 have now been launched

A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders and immune-mediated diseases.

Among other things, the topics aim to make clinical trials more patient-centric, contribute to medicines safety, and apply blockchain technologies to the drug development and health sectors.

Read more

News

19072018 European Semester: Country Specific Recommendations 2018
19 July 2018

EFPIA welcomes a continued debate on European healthcare reform to both improve health outcomes for patients and increase... Read more

Blogs

19072018 Japan calling: Environment in Focus of the 45th Annual Conference of Japanese Society...
19 July 2018 - Sini Eskola

Sini Eskola underlines that a multi-stakeholder approach is required to address the concerns around Pharmaceuticals... Read more

Videos

A lifetime of breakthroughs
We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades of tireless... Read more

Fighting infections for a Brighter Tomorrow
New microbiome therapies could prevent C.difficile infections reoccurring Read more

We published

2018: The pharmaceutical industry in figures
28 June 2018 (Publications)

The Pharmaceutical Industry: a key asset to scientific and medical progress Read more

What we are watching

[Video] Brexit: What would no-deal mean for the pharmaceutical industry?
On 17 July 2018 (BBC Newsnight)

Helen Thomas reports on how the pharmaceutical industry is preparing for the possibility of a no-deal Brexit Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu